Editorial Comment: Which MRI Contrast Agent for Hepatocellular Carcinoma Diagnosis in LI-RADS? The Fog Is Lifting

AJR Am J Roentgenol. 2022 Apr;218(4):698. doi: 10.2214/AJR.21.27171. Epub 2021 Dec 8.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Carcinoma, Hepatocellular* / diagnostic imaging
  • Carcinoma, Hepatocellular* / pathology
  • Contrast Media
  • Humans
  • Liver Neoplasms* / diagnostic imaging
  • Liver Neoplasms* / pathology
  • Magnetic Resonance Imaging
  • Tomography, X-Ray Computed

Substances

  • Contrast Media